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INTRODUCTION
Runx proteins belong to a family of heterodimeric transcription factors, PEBP2/CBF, that controls critical cell fate determination in several lineages (Ito, 2008) and is composed of two subunits: a DNA-binding a subunit, and a non-DNA-binding b subunit (Cbfb) . The a subunit in mammals is encoded by three Runx family genes, namely Runx1, Runx2, and Runx3. RUNX1 or AML1 is one of the most frequently mutated genes in human leukemias (Ley et al., 2013; Osato, 2004; Speck and Gilliland, 2002) . RUNX3 and CBFB are also shown to be associated with leukemogenesis (Liu et al., 1993; Maddipoti et al., 2008) . Furthermore, recent findings showed the presence of RUNX1 and CBFB mutations in breast cancer (Banerji et al., 2012) and RUNX3 involvement in lung cancer (Lee et al., 2013) .
Conditional knockout (cKO) of Runx1 results in transient hematopoietic stem cell (HSC) expansion and subsequent exhaustion (Jacob et al., 2010; Motoda et al., 2007) . Runx3 cKO mice reveal a mild expansion of myeloid cells and HSCs when aged, partially phenocopying Runx1 cKO mice (Wang et al., 2013b) . Because Runx family genes were expected to have a compensatory mechanism, we generated hematopoietic-specific Runx1; Runx3 double-knockout (DKO) mice. Strikingly, concurrent disruption of Runx1 and Runx3 resulted in mouse lethality due to bone marrow failure (BMF) or myeloproliferative disorder (MPD). Such clinically opposing manifestations are also seen in human inherited bone marrow failure syndromes (IBMFSs) that are known to be caused by defective DNA damage repair. Fanconi anemia (FA) is the most common disease constituting IBMFSs, characterized by progressive BMF and cancer predisposition, being caused by the biallelic disruption of FA gene products that participate in the repair of DNA interstrand crosslinks (ICLs) (Moldovan and D'Andrea, 2009 ). Interestingly, FA-like clinical manifestations were recently reported in two human patients with chromosome 21q deletions in the region encompassing RUNX1 (Byrd et al., 2011; Click et al., 2011) . Because these patients did not exhibit mutations in FA genes tested, it was suggested that deletion of RUNX1 might be the cause for FA-like clinical symptoms.
Thus, we interrogated whether the phenotypes of Runx1; Runx3 DKO mice represented a FA-like manifestation. We show that combined ablation of Runx1 and Runx3 in both mice and human cell lines leads to FA phenotypes and describe a role for RUNX in the recruitment of FANCD2, a central protein of the ICL repair pathway. Interestingly, the DNA repair function of Runx is independent of Cbfb, suggesting a nontranscriptional role of Runx in DNA repair. Our findings have unraveled a previously unappreciated intimate link between RUNX and FA. Runx3 fl/fl ;Mx1-Cre À mice were generated and injected with polyinosinic-polycytidylic acid (pIpC) at 4 weeks of age to induce Cre expression. Hereafter, these mice are referred to as Runx1; Runx3 DKO mice and Runx1;Runx3 wild-type (WT) mice, respectively. The deletion efficiency of floxed alleles after Cre expression was nearly complete in the bone marrow (BM) from Runx1;Runx3 DKO mice ( Figure S1A ).
BMF Mice
Complete blood counts (CBCs) in peripheral blood (PB) were monitored fortnightly. At 4 weeks after pIpC injection, 82% (14 out of 17) of Runx1;Runx3 DKO mice had decreased white blood cell (WBC) and platelet (Plt) counts, compared to WT mice (Figure 1A , top and middle panels). Moreover, Runx1;Runx3 DKO mice developed anemia, evident from decreased hemoglobin (Hb) levels, at later time points ( Figure 1A , bottom panel). These mice, termed BMF Runx1;Runx3 DKO mice, died within 18 weeks postinduction ( Figure 1B ). Necropsy of BMF Runx1;Runx3 DKO mice revealed smaller spleen size and almost undetectable thymus ( Figure 1C ). BM cellularity was slightly lower in BMF Runx1;Runx3 DKO mice than WT mice ( Figure 1D ). Flow cytometric examination demonstrated that before BMF development, Runx1; Runx3 DKO mice consistently showed decreased lymphoid and erythroid populations, accompanied by a relative increase in myeloid population, as compared to WT mice ( Figure 1E ). MPD Mice Surprisingly, the remaining 18% (3 out of 17; represented by open circles in Figure 1B ) of the Runx1;Runx3 DKO mice showed high WBC counts of above 50 3 10 3 /ml ( Figure 1F ). Flow cytometric and morphological analyses of PB and BM cells from these mice showed that high WBC counts were largely due to expanded c-Kit
+ myelocytes with ring-shaped nuclei ( Figures 1G and 1H ). These data indicate that the Runx1;Runx3 DKO mice succumbed to MPD or leukemia. In a transplantation assay using BM cells from a diseased mouse, leukocytosis was recapitulated only in a small number of recipient mice with a long latency. Therefore, this phenotype in Runx1;Runx3 DKO mice is more appropriately defined as MPD, but not leukemia. Such mice are termed as MPD Runx1; Runx3 DKO mice. Because Runx1;Runx3 DKO mice develop BMF or MPD only after a time lapse, Runx1;Runx3 DKO mice at presymptomatic stage are hereafter referred to as pre-BMF/MPD mice unless otherwise stated ( Figure 1I ). Runx1;Runx3 DKO mice was analyzed by flow cytometry and was shown to be drastically increased in the BM and spleen (Figures 2A-2D ). Gene expression profiles (GEPs) of Runx1;Runx3 DKO KSL cells were assessed to gain an insight into the mechanism(s) underlying the drastic expansion of KSL population. Gene set enrichment analysis (GSEA) revealed that a key HSC self-renewal pathway, the Wnt pathway (Mosca et al., 2013) , was activated in Runx1;Runx3 DKO KSL cells ( Figure 2E ), whereas Wnt inhibitors and antagonists, such as Dkkl1 and Sfrp factors (Cain and Manilay, 2013; Wang et al., 2013a) , were suppressed ( Figure 2F ). Wnt activation in Runx1;Runx3 DKO cells can be conferred by the loss of direct suppression by Runx proteins or by transcriptional upregulation of activators. For example, Fancl, which ubiquitinates and activates b-catenin (Dao et al., 2012) , was upregulated ( Figure 2G ). Luciferase assay further confirmed that RUNX1 and RUNX3 suppressed the expression of Fancl in a DNA-binding-and dosedependent manner ( Figure 2H ). In addition, similar to Runx1 cKO HSCs (Motoda et al., 2007) , GEPs and quantitative realtime PCR showed upregulation of Bmi1, another important HSC self-renewal factor. Analysis of GEP data further demonstrated the downregulation of critical HSC niche-related factors Cxcr4, Vcam-1, and Robo4 in Runx1;Runx3 DKO KSL cells (data not shown). It is plausible that the loss of niche-related factors led to detachment of quiescent long-term (LT) HSCs in the niche, which in turn caused an increase of rapidly cycling short-term (ST) HSCs. Similar to Runx1 cKO mice (Jacob et al., 2010) , the weakened niche interaction is likely to be the basis for HSC expansion in Runx1;Runx3 DKO mice. Consistently, further analysis revealed decreased LT-HSC, accompanied by increased ST-HSC, within the KSL fraction of Runx1;Runx3 DKO mice (Figures 2I and S1B) . A decrease in multipotent progenitors (MPPs) was also observed. Due to the massive expansion of Runx1;Runx3 DKO KSL cells, frequencies of LT-HSCs and MPPs in the BM were (D) Total BM cellularity in BMF Runx1;Runx3 DKO mice. Mean ± SEM of number of cells in two femurs from five independent experiments is shown (WT, n = 5; DKO, n = 5). Figure S1 .
BMF in
greater than WT levels ( Figure S1C ). Examination of specific hematopoietic progenitor compartments in the BM showed an increased granulocyte/macrophage progenitor (GMP) fraction and decreased common myeloid progenitor (CMP) and megakaryocyte/erythroid progenitor (MEP) fractions within the myeloid progenitor compartment (c-Kit Figure 2I ). However, lineage priming toward GMPs was not observed in the KSL population of Runx1;Runx3 DKO mice (data not shown). In addition, there were decreased common lymphoid progenitor (CLP) cells in the Runx1;Runx3 DKO BM.
GSEA demonstrated significant enrichment of leukemia stem cell (LSC)-related genes (Eppert et al., 2011) in Runx1;Runx3 DKO KSL cells ( Figure 2J ). Therefore, combined depletion of Runx1 and Runx3 appears to deregulate the core transcriptional program that controls normal and malignant stem cell behavior, including self-renewal capability, thereby contributing to the dramatic expansion of Runx1;Runx3 DKO KSL cells.
Stem Cell Exhaustion and Differentiation Blocks across All Hematopoietic Lineages Lead to BMF in Runx1;Runx3 DKO Mice HSPC frequencies from BMF mice were quantified to study the contradictory phenomenon of HSPC expansion culminating into BMF. In BMF Runx1;Runx3 DKO mice, the expansion of the BM KSL compartment significantly decreased by 5-fold (p < 0.05, Student's t test) from the initial 48.7-fold increase in pre-BMF/MPD Runx1;Runx3 DKO mice, to an average of 9.6-fold increase in BMF mice (Figures 2A, bottom panel, and 2B) . This progressive reduction in KSL cells indicated HSC exhaustion similar to Runx1 cKO mice (Jacob et al., 2010) .
The complete lack of blood production was too severe to be explained by HSC exhaustion alone. Therefore, Runx1; Runx3 DKO mice were examined for additional hematopoietic defects. Flow cytometric analysis revealed significant maturation blocks in B and T cell precursors from pre-pro- Figure 3D ).
Interestingly, there was a significant expansion of Mac-1 + Gr-1 À/low immature granulocytes with ring-shaped nuclei in the BM of Runx1;Runx3 DKO mice ( Figure 3E ). Because the expansion of immature cells was accompanied by the reduction in mature Mac-1 hi Gr-1 hi granulocytes, a blockage in terminal differentiation in granulocytes is thought to occur in Runx1;Runx3 DKO mice. A summary of these results is provided in Figure 3F . Briefly, combined loss of Runx1 and Runx3 inhibits the maturation of lymphocytes, megakaryocytes, and erythrocytes at early stages of development, whereas the blockage in granulocytes was observed at a relatively late stage, accompanied by the expansion of Mac-1 + Gr-1 À/low cells. We conclude that differentiation failure coupled with progressive stem cell exhaustion contributed to BMF in Runx1;Runx3 DKO mice.
Differentiation Blocks, HSPC Expansion, and MPD in Runx1;Runx3 DKO Mice Are Largely Cell Autonomous To assess whether the phenotypes in Runx1;Runx3 DKO mice were cell autonomous, bone marrow transplantations (BMTs) were conducted. Congenic strains of the pan-hematopoietic marker CD45 were used to distinguish the origins of repopulating cells ( Figure 4A ). At 8 weeks post-BMT, donor chimerisms reached $90% in the BM of recipient mice, and Runx1;Runx3 DKO-transplanted mice had lower WBC, Hb, and Plt counts than Runx1;Runx3 WTtransplanted mice ( Figure 4B ). Runx1;Runx3 DKO donor cells exhibited a skewed composition toward fewer B and T cells and more myeloid cells in the PB, BM, and thymus in the recipient mice, compared to Runx1;Runx3 WT donor cells (Figures 4C and 4D) . Runx1;Runx3 DKO donor KSL cells displayed substantial increase ( Figure 4E ; $14.7-fold increase), although less remarkable as the 48.7-fold increase in the earlier-mentioned non-BMT, pre-BMF/MPD Runx1;Runx3 DKO mice. The lethal phenotypes were recapitulated in Runx1;Runx3 DKO-transplanted mice, albeit less drastic than that of the Runx1;Runx3 Figure S2 ).
Absence of Runx1 and Runx3 Leads to Impaired ICL Repair
The BMF and MPD manifestations in Runx1;Runx3 DKO mice are reminiscent of human IBMFSs, whereby two contradictory phenotypes in a single patient are caused by defective DNA repair, which leads to either eradication of unrepaired damaged cells or the accumulation of tumor-promoting genetic mutations. Therefore, Runx1;Runx3 DKO mice were interrogated for defective DNA repair pathways leading to IBMFS. The susceptibility to DNA damage stimuli was observed as more Runx1;Runx3 DKO mice had succumbed to total body irradiation (TBI) as compared to their WT counterparts ( Figure 5A ). Correspondingly, persistent gH2AX foci indicative of increased DNA damage were observed in Runx1;Runx3 DKO KSL cells after in vitro irradiation (IR) ( Figure 5B ). Also, increased gH2AX+ population was detected by flow cytometry analysis ( Figure S3A ). Moreover, there was a greater fold reduction in the percentage of KSL fraction after TBI ( Figure S3B ). Micronuclei (MN), an indicator of DNA damage, showed increased accumulation in the PB cells of Runx1;Runx3 DKO mice after TBI ( Figure 5C ). These results suggest that defective DNA Asterisk(s) represents significant differences (*p < 0.05, **p < 0.01, ***p < 0.001, Student's t test). See also Figure S2 . (A) Survival of Runx1;Runx3 WT (n = 11) and Runx1;Runx3 DKO (n = 14) mice after total body IR. To avoid misinterpretation of lethality due to the spontaneous phenotypes in Runx1;Runx3 DKO mice, we examined the effects of IR at 2 weeks post-IR. Mean ± SEM of percentage of mice that died 2 weeks after IR (5 Gy Figure 5D ). In addition, GSEA using a gene set of downregulated genes in Fancc;Fancg DKO BM cells demonstrated a significant enrichment with the downregulated genes in Runx1;Runx3 DKO samples ( Figure 5E ), suggesting similarity between Runx1;Runx3 DKO mice and the FA mouse model.
Because a hallmark of FA cells is hypersensitivity to ICLinducing agents, progenitor cells from Runx1;Runx3 DKO mice were treated with mitomycin C (MMC). Runx1;Runx3 DKO cells showed decreased survival upon treatment with MMC (Figure 5F ), and cytogenetic analysis of treated Runx1;Runx3 DKO cells exhibited increased chromatid and chromosomal breaks ( Figure 5G ), which are consistent with FA phenotype.
To recapitulate the FA-associated phenotype in other cell types, double knockdown (DKD) of RUNX1 and RUNX3 (RUNX1; RUNX3 DKD) was achieved using a RNA-interference based knockdown (KD) strategy. Well-established cell lines for the study of FA, HeLa-S3, and HCT116 were used ( Figure 5H ). KD did not cause changes in cell viability (data not shown) or cell-cycle profiles ( Figure S3C ). RUNX1;RUNX3 DKD cells showed MMC hypersensitivity ( Figure 5I ), increased MMC-induced chromosomal breaks ( Figure S3D) , and elevated accumulation of MN before and after MMC treatment ( Figure S3E ). Similar results were obtained in a hematopoietic cell line: Jurkat ( Figure 5J ). BRCA1 KD cells were used as a positive control for the karyotype and MN analyses (Figures S3D-S3F) . Therefore, FA-like manifestations observed in Runx1;Runx3 DKO mice appear to be reproduced at least in human hematopoietic and epithelial cells tested, and they seemingly serve as a platform for further precise molecular analysis. (Kee and D'Andrea, 2010) . Notably, monoubiquitination of FANCD2 is necessary but insufficient for the formation of FANCD2 foci because FANCD2 monoubiquitination and foci formation can be uncoupled in specific contexts such as when Brca1, Snm1, or Usp1 are knocked down (Kim et al., 2009; Mason and Sekiguchi, 2011) . We interrogated four key steps of ICL repair in RUNX1;RUNX3 DKD cells: DNA damage checkpoint, FANCD2/ FANCI monoubiquitination, FANCD2 foci formation, and homologous recombination (HR) repair. Cell-cycle analysis showed that the extent of G 2 /M accumulation, as well as phosphorylation of CHK1 and p53, was similar between control and RUNX1; RUNX3 DKD samples after MMC treatment ( Figures S4A and  S4B ), suggesting intact ATR-mediated checkpoint activation.
Data from two cell lines (HeLa-S3 and HCT116) showed a similar extent of FANCD2 and FANCI monoubiquitination, measured by the ratio of monoubiquitinated versus unmodified proteins, in RUNX1;RUNX3 DKD and control cells after exposure to MMC ( Figures 6A and S4C) , suggesting intact ubiquitin ligase activity of the FA core complex. Interestingly, whereas 24 hr of MMC exposure induced robust FANCD2 foci formation in control cells, FANCD2 foci were not efficiently formed in RUNX1;RUNX3 DKD cells ( Figures 6B, 6C , and S5A). Defective FANCD2 recruitment was more discernible when Triton X-100 pre-extraction of soluble FANCD2 was performed before subsequent processing ( Figure 6C ). The defect was also quantified using automated image analysis software (ImageJ) ( Figure 6D ). The average fluorescence intensity of FANCD2 foci per cell was also reduced in RUNX1;RUNX3 DKD cells (562 fluorescence units in control cells versus 362 fluorescence units in RUNX1;RUNX3 DKD cells) ( Figure 6E ). Although some RUNX1;RUNX3 DKD cells still retained FANCD2 foci, it seems largely not due to low transfection efficiency of small interfering RNAs (siRNAs). Using fluorochrome-labeled RUNX1 and RUNX3 siRNAs, transfection efficiency was determined to be higher than 92% ( Figure S5B ), and the RUNX proteins were significantly depleted across all cells ( Figures S5C  and S5D ).
To independently confirm the above findings, a subcellular biochemical approach was used to assess FANCD2 recruitment ( Figure S5E ). Increasing amounts of FANCD2-Ub and FANCI (FANCI-Ub and unmodified form) were retained in the chromatin fractions of MMC-treated cells in a time-dependent manner (Figures 6F and S5F ). Interestingly, a modest increase in RUNX1 and RUNX3 levels was noted in fraction P2 upon MMC treatment, suggesting that a portion of RUNX complexes relocates to chromatin after DNA damage ( Figure 6F) . Strikingly, the chromatin recruitment of FANCD2 and FANCI was significantly lower in MMC-exposed RUNX1;RUNX3 DKD cells as compared to control cells ( Figure 6G ). These results confirm that the depletion of RUNX proteins leads to defective recruitment of FA proteins to sites of damage.
FANCD2 foci formation was also impaired at early time points ( Figure S5G ). Moreover, single depletion of RUNX1 or RUNX3 did not result in FANCD2 localization defects ( Figure S5H ). The observation that RUNX1;RUNX3 DKD samples showed defective FANCD2 recruitment at early time points indicated that this defect might be related to an upstream signal that controls the assembly of FANCD2-Ub foci. Recent studies using Brca1 D11/D11 murine cells have uncovered a role for Brca1 in the control of FANCD2 foci formation during ICL repair, which is independent of its role in HR (Bunting et al., 2012) . Similar to RUNX1;RUNX3 DKD, BRCA1 KD resulted in reduced FANCD2 foci formation ( Figures S5I and S5J ), although BRCA1 depletion does not affect the preceding FANCD2 monoubiquitination step (Vandenberg et al., 2003) . Upon MMC treatment of RUNX1; RUNX3 DKD cells, all cells deficient for FANCD2 foci were concurrently defective for BRCA1 foci formation (Figures 6H and S5K) . To study if RUNX1;RUNX3 DKD led to downstream defects in HR, the direct repeat-GFP (DR-GFP) reporter assay was used. Transient expression of the rare-cutting endonuclease, I-SceI, leads to double-strand breaks, and subsequent HR repair of the breaks results in GFP + cells that are quantifiable by flow cytometry ( Figure 6I , top). Because RUNX1;RUNX3 DKD cells have a defect at the level of FANCD2 foci formation, the extent of HR repair decreased by a mild $30% ( Figure 6I ). This phenotype is similar to the moderate defect in HR observed upon ablation of core FA genes (Nakanishi et al., 2005; Yamamoto et al., 2005) . In contrast, consistent with an essential role of BRCA1 in HR, GFP positivity was drastically reduced by 90% in BRCA1 KD cells.
RUNX1 and RUNX3 Control FANCD2 Recruitment to Sites of ICLs in a Cbfb-Independent Manner
Heterodimerization of Runx with Cbfb is required for the protein stability and transcriptional activities of Runx. Because GEP analysis of Runx1;Runx3 DKO cells did not reveal obvious (legend continued on next page) transcriptional changes in DNA repair pathways (Callen et al., 2013) (Figures S6A and S6B ), we predicted that Runx1 and Runx3 may function in a nontranscriptional capacity in DNA damage response. In that case, although Runx-mediated transcription would be largely abolished in Cbfb KO mouse, exposure to DNA-damaging agents may not render a DNA damage sensitivity phenotype. We generated Cbfb cKO mice in which the deletion efficiency of floxed alleles after pIpC treatment was nearly complete in the BM ( Figure S6C ). In contrast to Runx1;Runx3 DKO mice, Cbfb cKO mice did not show increased sensitivity to TBI compared to Cbfb WT mice ( Figure 7A ). Moreover, Cbfb cKO mice did not develop BMF or MPD (n = 9, 8 months old), although other phenotypes, namely HSPC expansion and differentiation blocks (unpublished data), were similar to the Runx1;Runx3 DKO mice. Because Cbfb ablation largely abolishes the transcriptional activity of all Runx proteins, the above observation strongly suggests that RUNX may function in DNA repair through mechanisms distinct from its canonical transcriptional role. Independent from the above-mentioned experiments, quantitative mass spectrometric analysis to discover RUNX3-interacting proteins identified FANCI as one of the high-confidence interactors (unpublished data). We examined whether RUNX can exercise its nontranscriptional role in DNA repair by physically associating with FANCD2-containing complexes. RUNX3 coimmunoprecipitated with exogenous and endogenous FANCD2 and FANCI ( Figures 7B-7D ), whereas Cbfb failed to do so, although it interacted with endogenous RUNX3 (Figure 7D ), suggesting that Cbfb was not incorporated into such DNA repair complexes. Similar results were obtained for RUNX1. These data suggest that the fraction of RUNX that exists in a complex with FANCD2 is mutually exclusive from the RUNX/Cbfb complex.
To study if MMC treatment stimulated the interaction of RUNX1 and RUNX3 to FANCD2, subnuclear distribution of these proteins was examined. Upon MMC treatment, a fraction of RUNX1 foci colocalized with FANCD2 foci ( Figure S6D ). Because most RUNX proteins are localized to transcription-associated nuclear matrix foci (Zaidi et al., 2002) , it was difficult to correctly estimate the percentage of colocalization with FANCD2 foci. However, coimmunoprecipitation assays clearly revealed an increased association between RUNX3 and FANCD2 after MMC treatment (Figures S6E and S6F) . Identical results were obtained when the association of overexpressed RUNX3 or RUNX1 with endogenous FANCD2 was examined after exposure to MMC (Figures 7E and 7F) . Physiological relevance of RUNX-FANCD2 interaction was further ascertained by endogenous immunoprecipitation of RUNX1/RUNX3/FANCD2 complexes from MMC-exposed nuclear extracts of Jurkat cells ( Figure 7G ). Consistent with Cbfb-independent interaction between RUNX and FANCD2, Cbfb does not bind to FANCD2 even after exposure with MMC ( Figure S6G ).
We conclude that defective DNA repair contributes to the lethal phenotypes in Runx1;Runx3 DKO mice. This was confirmed by increased basal levels of DNA damage in Runx1;Runx3 DKO cells as assessed by increased gH2AX staining in BM cells ( Figure 7H ) and increased MN in PB reticulocytes (RETs) ( Figure 7I ).
RUNX1-ETO Fusion Protein Causes the Defect in the FA DNA Damage Repair Pathway
Finally, we studied the clinical relevance of RUNX participation in DNA damage repair using hematopoietic cell lines carrying RUNX alteration. Kasumi-1 is a RUNX1-ETO fusion gene-expressing human leukemic cell line, in which the fusion protein (D) Coimmunoprecipitation of endogenous FANCD2 and FANCI with RUNX3, but not Cbfb, in HEK293T cells. GFP-tagged Cbfb, EGFP-tagged RUNX3, or empty EGFP-expressing plasmids were overexpressed in HEK293T. Lysates were coimmunoprecipitated using GFP beads, and western blots were probed with indicated antibodies. (E and F) Coimmunoprecipitation of endogenous FANCD2 with RUNX3 and RUNX1 is enhanced after MMC treatment in HEK293T cells. EGFP-RUNX3 (E) or EGFP-RUNX1 (F) was overexpressed and left untreated or exposed to 1 mM MMC. Cell lysates were coimmunoprecipitated using GFP beads, and western blots were probed with indicated antibodies. Blots were probed for phosphorylation of p53 (ser15) is thought to suppress the expression and/or function of both RUNX1 and RUNX3 simultaneously. Thus, the expression of RUNX1-ETO is expected to cause defective DNA damage repair and a DNA damage-hypersensitive phenotype. We confirmed that Kasumi-1 cells were indeed sensitive to MMC, and the KD of RUNX1-ETO reduced this sensitivity ( Figure 7J ). Similar behavior was seen in another RUNX1-ETO-expressing leukemic cell line: SKNO-1 (data not shown). Moreover, whereas FANCD2 monoubiquitination remained unaffected ( Figure 7K ), depletion of RUNX1-ETO led to increased FANCD2 recruitment to chromatin both in the absence and presence of MMC (Figure 7L) . The above results suggest that RUNX1-ETO might repress FANCD2 foci formation and ICL repair in human leukemic cells.
One of the outcomes of FA pathway abnormality is defective HR repair, which in turn becomes addicted to alternative DNA repair pathways, such as nonhomologous end-joining and base excision repair (BER). It was hence predicted that RUNX dysfunction would sensitize cells to inhibition of BER-mediating PARP-1 (Carey and Sharpless, 2011; Ellisen, 2011) . Thus, Kasumi-1 cells were treated with two PARP inhibitors: Olaparib or Rucaparib. Parental Kasumi-1 cells were more sensitive to PARP inhibitor, and the KD of RUNX1-ETO partially reduced this sensitivity ( Figure 7M ; data not shown). The efficacy of PARP inhibitor was further accentuated when cells were treated with MMC, indicating that the synthetic lethal effects of PARP-1 inhibition and MMC exposure could potentially be considered for targeting RUNX leukemia ( Figure 7N ).
DISCUSSION
The functional redundancy between Runx1 and Runx3 was unveiled by the lethality in Runx1;Runx3 DKO mice due to BMF, caused by multiple differentiation blocks and stem cell exhaustion, or preleukemic condition, MPD, which were not observed in the respective single cKO mice (Runx1 cKO, n = 36; Runx3 cKO, n = 35). We found that Runx1 and Runx3 play important roles in DNA repair, particularly the FA pathway where RUNX proteins facilitate the recruitment of FANCD2-Ub to sites of DNA damage ( Figure S7 ). This report illustrates a direct relationship between Runx family genes and the FA pathway. The property of Runx1 and Runx3 in the FA pathway is independent of their roles as transcription factors and appears to be a basis for the antitumorigenic roles of Runx in leukemia and solid tumor development.
The simultaneous occurrence of the two contradictory manifestations, BMF and MPD, in Runx1;Runx3 DKO mice was reminiscent of human IBMFS. Of the several types of IBMFSs, we focused on FA because recent reports described that chromosome 21q deletion containing RUNX1 was found in two FA-like patients. Using multiple approaches, we showed that ablation of both Runx1 and Runx3 led to defective DNA repair. These results suggest that RUNX1 deletion might predispose the patients to FA-like conditions. Just as compound deficiency of Runx3 in addition to Runx1 was required for the FA-like phenotypes in mice, additional genetic change(s) besides RUNX1 malfunction is also considered to be required for the manifestation of FAlike conditions in the human patients. SOD1, located within the deleted chromosome 21q region, seems to be an interesting candidate. SOD1 encodes a superoxide dismutase to detoxify reactive oxygen species (ROS). Notably, SOD1 is suppressed in FA cells, causing their hypersensitivity to oxidants and MMC (Kumari et al., 2014) . Identification of the deleted gene(s) responsible for the FA-like phenotypes would provide us with profound insights into RUNX function in the FA pathway. Recent technological advances have shown frequent deletions of chromosome 21q, including the RUNX1 locus, in patients with congenital syndromic thrombocytopenia with leukemia predisposition. We propose that FA-like cellular features should be investigated in the patients with syndromic thrombocytopenia.
Although Runx1;Runx3 DKO mice recapitulated FA phenotypes, some discordances exist between Runx1;Runx3 DKO mice and FA patients/mouse models. The HSC compartment is usually decreased in FA but showed a massive expansion before subsequent decline in the pre-BMF/MPD Runx1;Runx3 DKO mice. Therefore, the reasons for the HSC expansion were extensively sought in Runx1;Runx3 DKO mice and were shown to be attributable to multiple mechanisms, including (1) increased HSC self-renewal capability due to the elevation of Bmi1 and activation of the Wnt pathway, (2) the detachment from niches responsible for HSC quiescence, and (3) increased expression of LSC-associated genes. All of these abnormalities, which are unlikely to be present in the cells of patients with FA, seem to clarify the differences in HSC compartments. Alternatively, it is possible that, at an early time point before clinical onset of BMF, IBMFS patients or mouse models may show HSC expansion to some extent as a compensatory increase in response to loss of mature hematopoietic cells and subsequent increased cytokine secretion as homeostatic machinery. This kinetics scenario has not been carefully examined in human patients or mouse models in earlier studies. Interestingly, one of the FA mouse models, Usp1 KO mice, showed an increase in the size of its HSC compartment (Parmar et al., 2010) . Usp1 encodes ubiquitin-specific peptidase 1, a ubiquitin-specific protease that serves to deubiquitinate the FANCD2/FANCI heterodimer. Therefore, the level of Fancd2-Ub was enhanced in Usp1 KO mice. However, Fancd2 foci formation was abrogated, resulting in MMC hypersensitivity of Usp1 KO cells. These similarities in key phenotypes between Usp1 KO and Runx1;Runx3 DKO mice may help to further dissect RUNX functions in the FA pathway.
RUNX1 is among the most prevalent leukemia genes, and RUNX3 is also associated with human leukemias. Notably, simultaneous suppression of the expression and/or function of both RUNX1 and RUNX3 was shown in acute myeloid leukemia with t(8;21) or inv(16) due to the fusion proteins (Cheng et al., 2008; Meyers et al., 1996) . Therefore, the DNA damage response defects seen in Runx1;Runx3 DKO mice may also be the mechanistic basis for leukemogenesis in common human RUNX leukemias. Our results clearly demonstrated that human leukemia cell lines expressing the RUNX1-ETO fusion gene are sensitive to MMC, at least partially in a fusion gene-dependent manner. This sensitivity was further enhanced in the presence of PARP inhibitor. This treatment with PARP inhibitors, together with DNA ICL and/or standard chemotherapy drugs, could be applied for RUNX leukemia. Because deregulation in RUNX family genes is now found in a wide spectrum of cancers, this combined therapy can potentially be extended to common cancers.
EXPERIMENTAL PROCEDURES Mice

Runx1
fl/fl (Taniuchi et al., 2002) Cell Lines, Plasmids, and Transfection Human embryonic kidney 293T (HEK293T), HCT116, and HeLa-S3 cell lines were procured from American Type Culture Collection. Cells were cultured by supplementing Dulbecco's modified Eagle's medium with 10% fetal bovine serum. Plasmids encoding human FLAG-RUNX3, EGFP-RUNX3, EGFP-RUNX1, and mouse EGFP-Cbfb were described earlier by Chuang et al. (2012) and Yano et al. (2006) , and a plasmid-encoding mouse FLAG-Cbfb was constructed for the current study. HA-FLAG-tagged FANCI and FLAG-FANCD2 were kindly provided by A. Smogorzewska and N. Matsushit, respectively. HeLa-S3 stably integrated with DR-GFP was a kind gift from J. Parvin.
For overexpression experiments in HEK293T, TransIT-293 transfection reagent was used according to the manufacturer's instructions.
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